ANNECY, France, June 30, 2011 /CNW/ - Over 70 international experts in
medicine, infectious diseases, microbiology and epidemiology, from
every continent, gathered at the Fondation Mérieux's Conference Center
for the third edition of the World HAI Forum on healthcare-associated
infections, a bioMérieux initiative. Forum participants call upon
national and international health authorities and policy makers, the
medical and veterinary communities, Industry, and the general public to
take action to avoid an impending public health catastrophe caused by
the emergence and spread of bacteria that are resistant to all
While research to discover novel antibiotics has slowed to a virtual
standstill, bacterial resistance has increased due to the massive use
and misuse of antibiotics, not only for human health, but also for
animals. The treatment of certain common infections is becoming
difficult and the success of immunosuppressive therapies and surgical
interventions (organ transplants, cardiac surgery), which are
associated with a high risk of bacterial infection, could be
To the Forum experts, the emergence of pan-resistant NDM-1 bacteria and
epidemic of multidrug-resistant E. coli infections currently in Europe should be taken as a major public health
warning, indicating that a new era of antimicrobial resistance has
begun. This must lead to a global awakening: the protection of
antibiotics has now entered the sphere of sustainable development.
In a continuation of calls to action and proposals made by major
national and international organizations (WHO, ECDC, IDSA, CDC, etc.),
the Forum's participants identified priority action areas to fight
bacterial resistance and recommended 12 very concrete actions to be
implemented, in the short to mid-term, to effectively address this
Priority actions for policy makers and health authorities
For animals, stop the administration of antibiotics used in human
medicine and limit antibiotics to therapeutic use only. It is
imperative to reserve the most important classes of antibiotics for
Banish, in all countries, the use of antibiotics as growth promoters in
Regulate the sale of antibiotics for use in human medicine and prohibit
over-the-counter sales worldwide.
Have international organizations (WHO, European Union) develop a charter
on good antibiotic stewardship and have all the ministries of health
worldwide sign it and commit to respecting it.
Priority actions for the human and veterinary healthcare communities
Establish standardized, universal surveillance of antibiotic use and
resistance and monitor the emergence and spread of new forms of
Include, in the medical and veterinary school curricula, a solid
training in bacterial resistance and the prudent use of antibiotics and
establish on-the-job training programs for healthcare workers, taking
into account the cultural specificities of each country.
Priority actions for the general public
Develop culturally sensitive awareness campaigns, targeted to the
general public, explaining the importance of protecting antibiotics and
using them only when absolutely necessary.
Provide education about fundamental hygiene, such as handwashing to
prevent the spread of infection. It is imperative to improve sanitation
systems to eliminate resistant bacteria in wastewater.
Include consumers in the development and implementation of action plans.
Priority actions for lndustry
Develop Point-of-Care and rapid diagnostic tests, which can be used at
the patient's bedside or the doctor's office, to guide the prescription
of antibiotics and avoid their prescription for viral infections.
Stimulate research and development of novel antibiotics.
Find new economic models, which reconcile public health interests with
Industry needs for profitability.
About the World HAI Forum
To hear what experts discussed at the Forum: http://www.hai-forum.com
For more information visit:http://www.bioMerieux.com/hai-resistance
Organized from June 27-29, the 3rd edition of the World HAI Forum was
characterized by the exceptional geographical diversity of its
participants, coming from 33 countries.
While most meetings focus on scientific developments retrospectively in
an academic format, the World HAI Forum, which is held every two years,
gives participating experts a chance to do prospective analysis of
subjects that are not usually discussed. More time is devoted to
sharing best practices, successes and failures in the fight against
multidrug-resistant bacteria, as a basis for building effective action
A world leader in microbiology and a pioneer in resistance detection and
susceptibility testing, bioMérieux works closely with healthcare
professionals in the three key areas of Infection Control: Prevention,
Surveillance and Intervention. Diagnostic tests are paramount to
success in the fight against infections with resistant bacteria.
As part of its commitment to fight HAIs and microbial resistance,
bioMérieux has also held HAI symposia around the world over the past 3
years, in countries including the United States, Belgium, the
Netherlands, Portugal, Spain, China, Japan, Korea, Colombia and Saudi
Advancing Diagnostics to Improve Public Health
A world leader in the field of in vitro diagnostics for over 45 years, bioMérieux is present in more than150
countries through 39 subsidiaries and a large network of distributors.
In 2010, revenues reached €1.357 billion with 87% of sales outside of
bioMérieux provides diagnostic solutions (reagents, instruments,
software) which determine the source of disease and contamination to
improve patient health and ensure consumer safety. Its products are
used for diagnosing infectious diseases and providing high medical
value results for cancer screening and monitoring and cardiovascular
emergencies. They are also used for detecting microorganisms in
agri-food, pharmaceutical and cosmetic products.
bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM -
ISIN: FR0010096479). Other information can be found at http://www.biomerieux.com.
For further information:
Tel: + 33-4-78-87-20-08
Tel: + 1-910-509-3976